Pushkar M Kulkarni Selected Research

2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenol

1/2017	Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.
5/2016	Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.
10/2015	Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pushkar M Kulkarni Research Topics

Disease

5	Pain (Aches) 01/2020 - 10/2015
4	Hyperalgesia 01/2020 - 10/2015
2	Inflammation (Inflammations) 01/2020 - 01/2017
1	Corneal Injuries 01/2020
1	Huntington Disease (Huntington's Disease) 01/2019
1	Pathologic Processes 01/2018
1	Ocular Hypertension (Glaucoma, Suspect) 10/2017
1	Ataxia (Dyssynergia) 01/2017
1	Neuralgia (Stump Neuralgia) 01/2017
1	Cognitive Dysfunction 05/2016
1	Chronic Pain 10/2015

Drug/Important Bio-Agent (IBA)

3	3- (2- nitro- 1- phenylethyl)- 2- phenyl- 1H- indoleIBA 01/2020 - 11/2018
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020 - 11/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 10/2015
3	2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA 01/2017 - 10/2015
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2017
2	Freund's AdjuvantIBA 11/2018 - 10/2015
2	CannabinoidsIBA 11/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2015
2	Formaldehyde (Formol)FDA Link 01/2017 - 10/2015
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2017 - 10/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 10/2015
1	Capsaicin (Zostrix)FDA Link 01/2020
1	LigandsIBA 01/2020
1	Transient Receptor Potential ChannelsIBA 01/2020
1	Pharmaceutical PreparationsIBA 10/2017
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2015

Therapy/Procedure

1	Cautery 01/2020
1	Drug Therapy (Chemotherapy) 01/2017